Sermorelin and CJC-1295: Research Peptide Profiles
Sermorelin and CJC-1295 come up together constantly in research discussions because they act on the same pathway. For a research lab, the practical differences are about structure and stability, not about any human outcome. This profile is informational and for laboratory research only.
The shared pathway
Both compounds are analogs of growth-hormone-releasing hormone, or GHRH. In endocrine research models they are studied for how they interact with GHRH receptors. That shared mechanism is why they are frequently characterized side by side.
Sermorelin
Sermorelin corresponds to a truncated active fragment of GHRH. In research settings it is valued as a relatively well-defined analog with a short half-life in the models where it is studied. That short duration makes it useful for research designs that need a compound to clear quickly.
CJC-1295
CJC-1295 is a modified GHRH analog engineered for greater stability. Research literature distinguishes two forms: one with a DAC (drug affinity complex) modification designed for extended activity, and one without. If you source CJC-1295, the single most important thing to confirm is which form the COA describes, because they behave differently in the models that use them.
Why identity testing matters more here
These are longer, more complex sequences than a compound like GHK-Cu, and synthesis errors are easier to hide behind a good-looking purity percentage. For research reproducibility:
- Mass spectrometry should confirm the exact sequence and any modification, not just the approximate mass.
- HPLC purity should be documented for the specific batch.
- The form (with or without DAC, for CJC-1295) should be stated explicitly.
Handling
Both are peptides that require cold storage as lyophilized powder and careful handling once reconstituted. Aliquot and minimize freeze-thaw cycles. See our handling notes.
A quick reminder that applies to every compound we cover: sermorelin and CJC-1295 are research chemicals. Any source presenting them with dosing or human-use framing is not a research supplier. LNK Peptides provides both for laboratory and research use only, lab-tested with a COA on every batch.
About anecdotal reports: Where this article mentions what people "report" or "describe," those are unverified, anecdotal accounts shared by third parties online. They are not results we have observed, measured, or tested, and they are not evidence of anything. We make no health, performance, or cosmetic claims, we cannot and do not guarantee any result, and we do not endorse or condone use of these compounds outside controlled laboratory research.
Research use only: important disclaimer
This article is for educational purposes and summarizes findings from published laboratory and preclinical research. It is not medical advice and is not a claim about safety or effectiveness in humans. LNK Peptides sells all compounds strictly for laboratory and research purposes only. Products are not for human or animal consumption and are not drugs, supplements, cosmetics, or medical devices. These statements and products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. We do not endorse, encourage, or condone use of these compounds outside controlled laboratory research, and make no representation that any finding described will occur in any other context.
Sourcing lab-tested research peptides in Lincoln?
LNK Peptides supplies third-party lab-tested compounds with a COA on every batch. Research use only.
Apply for access